Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 591 entries
View as:

Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)

Phase: N/A Priority: Normal
NCT ID: NCT06381648 Org: User:
Start: 04/15/23 End: 06/18/26 Due: 06/18/27

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes) for the Treatment of Primary Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05625594 Org: User:
Start: 06/29/23 End: 05/21/26 Due: 05/21/27

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03746769 Org: User:
Start: 07/07/19 End: 08/01/28 Due: 08/01/29

The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05023993 Org: User:
Start: 06/23/22 End: 10/07/25 Due: 10/07/26

Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05672095 Org: User:
Start: 04/18/25 End: 11/27/26 Due: 11/27/27

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00788125 Org: User:
Start: 09/03/08 End: 07/30/22 Due: 07/30/23

Early Onset Colorectal Cancer Detection

Phase: N/A Priority: Normal
NCT ID: NCT06342401 Org: User:
Start: 04/15/23 End: 10/15/25 Due: 10/15/26

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03063918 Org: User:
Start: 04/28/17 End: 09/07/21 Due: 09/07/22

MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01231386 Org: User:
Start: 11/30/09 End: 05/20/19 Due: 05/20/20

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00720135 Org: User:
Start: 01/31/08 End: 07/31/14 Due: 07/31/15

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03997162 Org: User:
Start: 10/11/18 End: 02/04/26 Due: 02/04/27

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression

Phase: N/A Priority: Normal
NCT ID: NCT04605614 Org: User:
Start: 08/15/22 End: 10/30/24 Due: 10/30/25

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00576979 Org: User:
Start: 03/04/08 End: 02/03/26 Due: 02/03/27

An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03993327 Org: User:
Start: 07/15/20 End: 06/04/24 Due: 06/04/25

Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04560439 Org: User:
Start: 06/15/22 End: 06/15/23 Due: 06/15/24

Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma

Phase: N/A Priority: Normal
NCT ID: NCT04497779 Org: User:
Start: 07/13/20 End: 06/10/25 Due: 06/10/26

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03494569 Org: User:
Start: 07/06/18 End: 10/11/25 Due: 10/11/26

Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03804164 Org: User:
Start: 02/10/20 End: 02/10/20 Due: 02/10/21

Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT01752231 Org: User:
Start: 07/23/13 End: 08/29/17 Due: 08/29/18

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00950144 Org: User:
Start: 12/31/08 End: 10/31/10 Due: 10/31/11

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06195891 Org: User:
Start: 05/24/24 End: 06/21/27 Due: 06/21/28

Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02048150 Org: User:
Start: 03/05/15 End: 02/01/23 Due: 02/01/24

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT01612598 Org: User:
Start: 07/31/12 End: 01/31/14 Due: 01/31/15

Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04014231 Org: User:
Start: 07/21/17 End: 06/02/25 Due: 06/02/26

Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04775355 Org: User:
Start: 04/14/21 End: 07/29/25 Due: 07/29/26